<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: There is limited knowledge about <z:e sem="disease" ids="C0856169" disease_type="Disease or Syndrome" abbrv="">endothelial dysfunction</z:e> in patients with <z:e sem="disease" ids="C0409980" disease_type="Disease or Syndrome" abbrv="">primary antiphospholipid syndrome</z:e> (PAPS) </plain></SENT>
<SENT sid="1" pm="."><plain>The purpose of this study was to evaluate endothelial function in patients with PAPS assessed by <z:chebi fb="4" ids="30225">positron</z:chebi> emission tomography </plain></SENT>
<SENT sid="2" pm="."><plain>METHODS AND RESULTS: A 3-phase protocol--rest, cold pressor test (<z:chebi fb="9" ids="27656">CPT</z:chebi>), and <z:chebi fb="3" ids="16335">adenosine</z:chebi> <z:chebi fb="4" ids="30225">positron</z:chebi> emission tomography with <z:chebi fb="0" ids="36935">nitrogen 13</z:chebi> ammonia--was used in 18 patients with PAPS and 18 healthy volunteers (HVs) </plain></SENT>
<SENT sid="3" pm="."><plain>Myocardial blood flow (MBF) was measured in each phase, with calculation of the endothelial-dependent vasodilation index, the increase in the MBF in response to <z:chebi fb="9" ids="27656">CPT</z:chebi>, and the myocardial flow reserve </plain></SENT>
<SENT sid="4" pm="."><plain>An important trend was found in the myocardial flow reserve (2.76 +/- 1.04 in PAPS group vs 3.27 +/- 0.72 in HV group, P &gt; .05), in the endothelial-dependent vasodilation index (1.19 +/- 0.31 in PAPS group vs 1.55 +/- 0.37 in HV group, P &lt; .05), and in the percent change in the MBF in response to <z:chebi fb="9" ids="27656">CPT</z:chebi> (from rest) (19% +/- 31% in PAPS group vs 55% +/- 37% in HV group, P &lt; .05) </plain></SENT>
<SENT sid="5" pm="."><plain>CONCLUSION: The <z:chebi fb="9" ids="27656">CPT</z:chebi> results obtained in this study showed that the PAPS patients studied have <z:e sem="disease" ids="C0856169" disease_type="Disease or Syndrome" abbrv="">endothelial dysfunction</z:e> </plain></SENT>
</text></document>